Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Tsuda

Showing results (141-150 of 476) with videos related to

Pageof 48
Sort By:
Breast Cancer (Tokyo, Japan)|February 11, 2015
Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situNobuko Tamura, Hitoshi Tsuda, Masayuki Yoshida, et al.
Virchows Archiv : an International Journal of Pathology|April 6, 2012
Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesionsMiwa Yoshida, Hitoshi Tsuda, Sohei Yamamoto, et al.
The American Journal of Surgical Pathology|September 2, 2011
Important histologic outcome predictors for patients with invasive ductal carcinoma of the breastTakahiro Hasebe, Motoki Iwasaki, Sadako Akashi-Tanaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the LungKoji Tsuta, Yuko Tanabe, Akihiko Yoshida, et al.
Gynecologic Oncology|September 22, 2009
Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervixTakahiro Kasamatsu, Takashi Onda, Yuko Sasajima, et al.
Breast Cancer (Tokyo, Japan)|January 29, 2008
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)Masafumi Kurosumi, Sadako Akashi-Tanaka, Futoshi Akiyama, et al.
Pathology International|April 10, 2002
Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinomaHitoshi Tsuda, Hironobu Sasano, Futoshi Akiyama, et al.
Japanese Journal of Clinical Oncology|October 17, 2014
Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatmentMizuho Kikuyama, Sadako Akashi-Tanaka, Takashi Hojo, et al.
Annals of Diagnostic Pathology|October 19, 2010
Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasisNaobumi Tochigi, Koji Tsuta, Akiko Miyagi Maeshima, et al.
Cancer Science|October 21, 2006
PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinomaKen-ichi Kozaki, Issei Imoto, Atiphan Pimkhaokham, et al.
Pageof 48

Showing results (141-150 of 476) with videos related to

Sort By:
Pageof 48
Breast Cancer (Tokyo, Japan)|February 11, 2015
Clinicopathological predictive factors for ipsilateral and contralateral events following initial surgery to treat ductal carcinoma in situNobuko Tamura, Hitoshi Tsuda, Masayuki Yoshida, et al.
Virchows Archiv : an International Journal of Pathology|April 6, 2012
Loss of heterozygosity on chromosome 16q suggests malignancy in core needle biopsy specimens of intraductal papillary breast lesionsMiwa Yoshida, Hitoshi Tsuda, Sohei Yamamoto, et al.
The American Journal of Surgical Pathology|September 2, 2011
Important histologic outcome predictors for patients with invasive ductal carcinoma of the breastTakahiro Hasebe, Motoki Iwasaki, Sadako Akashi-Tanaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the LungKoji Tsuta, Yuko Tanabe, Akihiko Yoshida, et al.
Gynecologic Oncology|September 22, 2009
Prognostic significance of positive peritoneal cytology in adenocarcinoma of the uterine cervixTakahiro Kasamatsu, Takashi Onda, Yuko Sasajima, et al.
Breast Cancer (Tokyo, Japan)|January 29, 2008
Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version)Masafumi Kurosumi, Sadako Akashi-Tanaka, Futoshi Akiyama, et al.
Pathology International|April 10, 2002
Evaluation of interobserver agreement in scoring immunohistochemical results of HER-2/neu (c-erbB-2) expression detected by HercepTest, Nichirei polyclonal antibody, CB11 and TAB250 in breast carcinomaHitoshi Tsuda, Hironobu Sasano, Futoshi Akiyama, et al.
Japanese Journal of Clinical Oncology|October 17, 2014
Utility of intraoperative frozen section examinations of surgical margins: implication of margin-exposed tumor component features on further surgical treatmentMizuho Kikuyama, Sadako Akashi-Tanaka, Takashi Hojo, et al.
Annals of Diagnostic Pathology|October 19, 2010
Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasisNaobumi Tochigi, Koji Tsuta, Akiko Miyagi Maeshima, et al.
Cancer Science|October 21, 2006
PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinomaKen-ichi Kozaki, Issei Imoto, Atiphan Pimkhaokham, et al.
Pageof 48